2.1
Empagliflozin (Jardiance, Boehringer Ingelheim) is indicated for the treatment of 'chronic kidney disease (CKD) in adults'.
2 Information about empagliflozin
Dosage in the marketing authorisation
2.2
The dosage schedule is available in the summary of product characteristics for empagliflozin.
Price
2.3
The list price for empagliflozin is £36.59 for 28 tablets (10 mg and 25 mg) (excluding VAT; BNF online, accessed October 2023).